Firstly, GPX4 blocks the cell cycle's S-phase and inhibits lymphocyte proliferation, while also inhibiting the expression of 16 key upregulated pathogenic genes in inhibiting CDCA7 gene's expression significantly and lymphoma. This evidence concerns the gene GPX4 and lymphoma.